[Antibiotic treatment of brucellosis].

强力霉素 医学 抗生素 布鲁氏菌病 链霉素 利福平 药品 内科学 药理学 免疫学 肺结核 微生物学 病理 生物
作者
A. Bertrand
出处
期刊:PubMed 卷期号:23 (24): 1128-31 被引量:7
链接
标识
摘要

Forty years after active drug therapy was defined, the treatment of brucellosis still raises the problem of selecting the correct antibiotic and the duration of treatment. Indeed, requirements may be complex since one must select antibiotics which are active in vitro and which diffuse readily into the tissues and into the cells without developing bacterial resistance. Prescriptions must also be long enough, not only to achieve cure, but also to eliminate the Brucella strain. Antibiotics must be found which meet this last criteria yet do not lead to toxic effects or impair the patient's own immune response. Acute septicemic brucellosis in adult men and non-pregnant women has been effectively treated with the following three regimens: 1) doxycycline 200 mg/d and rifampin 900 mg/d orally for 45 days; 2) doxycycline 200 mg/d orally for 45 days and streptomycin 1 g/d IM for three weeks; 3) TMP-SMZ 320-1600 mg/d and rifampin 900 mg/d orally for 45 days. All regimens require a combination of two antibiotics and a prolonged course for total recovery, although casual relapses may occur. The doxycycline-rifampin combination shows the most favorable efficacy/safety ratio, and either antibiotic alone was used successfully in pregnant women by some investigators. The TMP-SMZ-rifampin combination is recommended in children below 8 years of age. Osteoarticular infections can be treated with doxycycline plus rifampin for 3 to 6 months, and streptomycin during the first 2 or 3 weeks. In nervous system complications, the preferred treatment is TMP-SMZ plus rifampin for 3 to 6 months. Brucellar endocarditis should be treated parenterally with streptomycin or gentamycin combined with TMP-SMZ, rifampin and doxycycline, and often requires valvular replacement. Many other antibiotics have been used with good clinical responses in the treatment of brucellosis, e.g., chloramphenicol, erythromycin, ampicillin, and more recently cephalosporins, thienamycin and fluoroquinolones; however, more cases have to be studied before any of these agents is definitely chosen for the treatment of brucellosis.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
故意的身影完成签到,获得积分10
1秒前
1秒前
墩墩发布了新的文献求助10
1秒前
2秒前
ei123应助安静柔采纳,获得50
2秒前
Cherish完成签到,获得积分10
3秒前
3秒前
4秒前
4秒前
wjh发布了新的文献求助10
4秒前
WWshu完成签到,获得积分10
5秒前
katarinabluu完成签到,获得积分10
5秒前
善学以致用应助墨羽采纳,获得10
6秒前
汉堡包应助虚心的冷雪采纳,获得10
6秒前
小石猛猛冲完成签到 ,获得积分10
7秒前
7秒前
7秒前
裘文献发布了新的文献求助10
7秒前
7秒前
7秒前
sccc发布了新的文献求助10
8秒前
小老鼠发布了新的文献求助10
8秒前
大模型应助光亮天蓉采纳,获得10
8秒前
123123发布了新的文献求助10
9秒前
LQY发布了新的文献求助10
10秒前
李文龙完成签到,获得积分10
11秒前
四憙完成签到 ,获得积分10
11秒前
天气发布了新的文献求助10
12秒前
Kavin完成签到,获得积分10
12秒前
小二郎应助高海龙采纳,获得10
13秒前
13秒前
maidang完成签到,获得积分10
13秒前
13秒前
14秒前
14秒前
15秒前
脑洞疼应助LQY采纳,获得10
15秒前
xiaohaitao发布了新的文献求助10
16秒前
伶俐从筠完成签到,获得积分10
16秒前
16秒前
高分求助中
Ophthalmic Equipment Market by Devices(surgical: vitreorentinal,IOLs,OVDs,contact lens,RGP lens,backflush,diagnostic&monitoring:OCT,actorefractor,keratometer,tonometer,ophthalmoscpe,OVD), End User,Buying Criteria-Global Forecast to2029 2000
A new approach to the extrapolation of accelerated life test data 1000
Cognitive Neuroscience: The Biology of the Mind 1000
Cognitive Neuroscience: The Biology of the Mind (Sixth Edition) 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 588
Christian Women in Chinese Society: The Anglican Story 500
A Preliminary Study on Correlation Between Independent Components of Facial Thermal Images and Subjective Assessment of Chronic Stress 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3961589
求助须知:如何正确求助?哪些是违规求助? 3507917
关于积分的说明 11138698
捐赠科研通 3240341
什么是DOI,文献DOI怎么找? 1790929
邀请新用户注册赠送积分活动 872649
科研通“疑难数据库(出版商)”最低求助积分说明 803306